Anti-platelet-activating factor, antibacterial, and antiradical activities of lipids extract from silver carp brain
© Wang et al.; licensee BioMed Central Ltd. 2013
Received: 25 April 2013
Accepted: 18 June 2013
Published: 27 June 2013
Epidemiological studies have verified the protective role of fish lipids in cardiovascular diseases. However, the effects of fish lipids on health boost remain undefined. Large amounts of by-products, such as fish brain which contains high level of lipids, are produced with silver carp processing. Fish brain is rich in bioactive lipids which are overwhelmingly effective in preventing cardiovascular diseases. The aim of this study was to elucidate the pharmacological activities of silver carp brain lipids against diseases by inhibiting platelet-activating factor (PAF), suppressing bacterial growth and scavenging free radicals.
Total lipids (TL) were extracted from silver carp brain and separated into polar lipids (PL) and neutral lipids (NL). The capabilities of the lipid fractions in aggregating washed rabbit platelet or in inhibiting PAF-induced platelet aggregation were tested. Their antibacterial and antiradical activities were studied as well.
The lipid fractions exhibited strong inhibitory activities, and the activity of TL was mainly attributed to NL. TL exhibited antibacterial activity towards Staphylococcus aureus, while NL managed to fight against S. aureus and Escherichia coli. PL excelled TL and NL in simultaneously suppressing the growths of Shigella dysenteriae and Salmonella typhi besides those of S. aureus and E. coli. The scavenging effect of PL on 2,2-diphenyl-1-picrylhydrazyl radical was considerably higher than those of TL and NL.
The present study may help to explain the protective role of fish lipids against diseases and may be responsible for the effectiveness of fish brain in benefiting health.
KeywordsSilver carp Brain lipids Platelet-activating factor (PAF) PAF antagonists Antibacterial Antiradical
Fish lipids have aroused intensive clinical interest due to the pharmacological activities against various diseases, the consumption of which prevents human chronic inflammatory, cardiovascular diseases and cancer. Although studies have been devoted to analyzing and explaining the role of fish lipids against various degenerative diseases, further studies are still needed and the types of fishes involved remain limited.
Silver carp (Hypophthalmichthys molitrix), as one of the main freshwater fish species in China, contributes 3,713,922 tons in 2011. However, over half of total fishery products are being discarded as inedible by-products every year. Traditionally considered physically and intelligently nutritious and beneficial, fish brain, as a derivative though, is popular in China and is thus of industrial interest nowadays. The advantages of fish brain stem from the high content and quality of lipids which, however, has seldom been accessed regarding health issues.
Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphocholine), which is key in atherosclerosis development, is also an extremely potent aggregating agent participating in the inflammatory development of plaque and the blockage of blood vessels that finally lead to coronary heart disease. Many foodstuffs contain molecules that inhibit the activity of PAF as PAF antagonists that are nutritionally valuable because they prevent platelets aggregation in arteries and atheromatosis generation simultaneously. Previous researches have revealed that lipids extracted from wild haddock and coley exhibited PAF-inhibiting activities.
Many foods primarily deteriorate because of microbes that give rise to the loss of quality and safety, on which people worldwide are concerning more because foodborne diseases are subject to outbreak due to pathogenic and spoilage microorganisms in foods. In addition, both Gram-positive and Gram-negative bacteria evoke a state of shock that is characterized by cardiovascular collapse. Numerous bacteria are able to produce PAF. For instance, PAF can be synthesized by being stimulated with Staphylococcus aureus toxins or it can be released by Escherichia coli. Given that PAF is an initial trigger in atherosclerosis, foodstuffs, which exert antibacterial activities, suppress the production of PAF, and therefore play a positive role in preventing atherosclerosis. Previous studies have demonstrated the lipids extracted from red shrimp brain, marine sponge, sea bass and gilthead sea bream exerted antibacterial activities[10, 12, 13]. Besides, antimicrobial agents have been prepared from the lipids of marine fishes.
Free radicals are engaged in the development of cardiovascular disease, cancer, liver disease and other chronic and inflammatory diseases based on oxidative damages, the scavenging of which therefore has been spotlighted. It has previously been reported that smokers displayed enhanced antioxidant capacity after being administered with fish oil which is associated with the reduced susceptibility of myocytes to injury-inducing reactive oxygen species upon dietary supplementation.
In the present study, the lipid fractions of silver carp brain were tested for their biological activities concerning platelet aggregation induction or PAF-induced platelet aggregation inhibition. The antibacterial activities of the lipids against E. coli, S. aureus, Shigella dysenteriae, Salmonella typhi and Listeria monocytogenes were examined. Moreover, their radical-scavenging effects were determined by utilizing 2,2-diphenyl-1-picrylhydrazyl (DPPH). The results may assist to explain the pharmacological activities of fish lipids against various diseases. Furthermore, the results may shed light on the commercial and industrial utilization of silver carp brain lipids as eligible bioactive ones.
Material and methods
Silver carps (1.5-2 kg) were purchased from a local market (Wuxi, Jiangsu Province) in April 2012. Live fish (n≥100) in water were transported to the laboratory, and then weighed and decapitated individually. The brain was removed, collected and homogenized. The prepared brain samples were kept at −70°C before lipids extraction.
Isolation of lipid fractions
Platelet aggregation assay
The biological activities of TL, NL and PL against washed rabbit platelets were tested as described previously, Briefly, PAF (Sigma) and the examined samples were dissolved in 2.5 mg bovine serum albumin (BSA) per ml of saline. Various concentrations of the sample were placed in an aggregometer (CHRONO-LOG, USA) cuvette and the resultant aggregatory effect was measured as the percentage of maximum reversible aggregation. The aggregatory activity of the sample was expressed as the amount inducing 50% of maximum reversible aggregation that was defined as EC50, i.e. equivalent concentration for 50% reversible aggregation. Samples at different concentrations were placed in an aggregometer cuvette to determine their abilities in inhibiting PAF-induced aggregation. The platelet aggregation induced by PAF (2.5×10-11 M, final concentration in the cuvette) was measured before (considered as 0% inhibition) and after adding the sample. Consequently, the dependence of percent inhibition on sample concentration was plotted, from which the concentration that inhibited 50% of PAF-induced aggregation was calculated and defined as IC50, i.e. concentration for 50% inhibition.
The antibacterial activities of TL, NL and PL against E. coli O157:H7 NCTC 12079, S. aureus NCBF 1499, L. monocytogenes NCTC 10527, S. dysenteriae ATCC 51302, and S. typhi ATCC 5784 were analyzed. The bacterial strains were cultured in Mueller-Hinton Broth except E. coli was cultured in Nutrient Broth otherwise. The antimicrobial activities of the lipids were determined by a modified paper disc diffusion method. Briefly, a suspension of the test microorganism (108 CFU/ml) was spread on solid media plates that were then incubated at 4°C for 2 h. Sterile 6 mm diameter filter paper discs were impregnated with 15 μl of diluted lipids and dried under nitrogen stream. Then the sterile paper discs were placed on an agar Petri dish and incubated at 37°C for 24 h, and a paper disc impregnated with 15 μl of mixed chloroform and methanol (1:1) was used as the control. After incubation, all dishes were observed for the zones of inhibition and the corresponding disc diameters (DD) were measured in millimeters.
Determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC)
The MICs of TL, NL and PL against the bacterial strains were evaluated according to the method of broth dilution. An aliquot of 5 ml nutrient broth supplemented with Tween 80 (0.5% v/v) was placed into each tube, and then all tubes were autoclaved at 121°C for 20 min. The lipids were added in the tubes and the final concentrations were kept at 0.1-25.6 mg/ml, to which was then added the test bacteria suspension that was kept at the final inoculum size of 106 CFU/ml. Thereafter the inoculated tubes were incubated at 37°C for 24 h. Culture medium without bacteria suspension was prepared as the control. MIC is defined as the lowest concentration of the lipids at which the microorganism does not demonstrate visible growth. Microorganism growth was indicated by the turbidity.
To determine MBC, broth was taken from each tube and inoculated in agar Petri dishes for 24 h at 37°C. MBC is defined as the lowest concentration of the lipids at which the inoculated microorganism was completely killed.
The inhibition concentration at which 50% of the DPPH radicals were scavenged (IC50’) was obtained by plotting the scavenging activity against the sample concentration.
All analyses were performed in triplicate, and all data were described as mean ± standard deviation (SD). Significant differences were defined at p<0.05. Group means were compared using ANOVA and Duncan’s tests. All statistics were performed using SPSS statistical package (version 18.0).
Platelet aggregation properties
Biological activities (aggregation of washed rabbit platelets or inhibition of PAF-induced platelet aggregation) of lipid fractions from silver carp brain
Content ( g /50g brain tissue)
Zones of growth inhibition, MIC and MBC of lipid fractions from silver carp brain
ω3 polyunsaturated fatty acids (ω3 PUFAs) in fish oil are potentially cardioprotective and antithrombotic. However, other substances, apart from ω3 PUFAs, may be responsible for the antithrombotic properties of fish oil. PAF antagonists in foodstuffs are nutritionally valuable considering the importance of platelet activation and thrombosis in cardiovascular diseases as well as the pivotal role of PAF in atherogenesis. PAF antagonists have been isolated from wild and cultured specimens of sea bass and gilthead sea bream. Previous studies have verified that the lipids extracted from cultured gilthead sea bream, wild gilthead sea bream, sea bass, and plaice had bimodal effects on washed rabbit platelet. However, the lipids from cultured rainbow trout and golden trout were only aggregatory, while those from wild haddock and coley were only inhibitory. Notably, the lipids from cultured sea bass were of aggregatory, inhibitory and bimodal effects in different analyses[6, 10, 25]. Therefore, the biological activities of fish lipids depend on species indeed. The aggregatory property and the PAF antagonistic activity of TL mainly originate from PL and NL respectively[6, 25]. Lipid fractions are intrinsically a mixture of lipid molecules that are potentially aggregatory or inhibitory. The final activity is governed by the relative ability of each molecule to aggregate platelet or to inhibit PAF-induced platelet aggregation and by the relative amount of each molecule in the mixture. It is also worth mentioning that the compounds with PAF-like activity in lipids are also beneficial as they act as weak PAF agonists and compete with PAF for common binding sites during the formation of atheromatic plaque in blood arteries, thus protecting them from atheromatosis generation. In other words, the compounds are literally PAF inhibitors.
Fish lipids are sufficient in ω3 PUFAs which have been proven antibacterially active. For instance, lipids of red shrimp brain inhibited the growths of S. aureus, S. dysenteriae and S. typhi, and TL from sea bass and gilthead sea bream inhibited the growth of S. aureus, while NL and PL suppressed those of E. coli and S. aureus. Fatty acids (FAs), which fight against many microorganisms, usually function relying on long-chain unsaturated fatty acids (LCUFAs) including oleic acid, linoleic acid, and linolenic acid. They all confront bacteria through several mechanisms of action, all of which primarily involve the perturbation of bacterial cell membrane. The bactericidal activity of LCUFAs against S. aureus enhanced with increasing degree of unsaturation. PL includes phospholipids which are richer in LCUFAs due to their functional role. Our previous research has confirmed abundant LCUFAs in silver carp brain especially in PL, which may be responsible for the antibacterial activities of the lipid fractions. In addition, cardioprotective sphingolipids, exist more abundantly in fish brain than in muscle, in which sphingosine is highly antibacterial. On the other hand, PAF antagonists also contribute to the antibacterial activities of lipid fractions by having antibacterial activities and by inhibiting bacterial-induced inflammatory actions. Consequently, the differences between the antibacterial activities of lipids from silver carp brain and those from other fish species can be ascribed to their different FA profiles, sphingolipids contents and PAF antagonist patterns.
Richard et al. reported that FA micelles scavenged superoxide in an unsaturation-dependent manner. In this study, the strong DPPH radical-scavenging effect of PL mainly results from the higher content of PUFAs, especially ω3 PUFAs, in PL than those in TL and NL (previously proven by our group). It is worth noting that in vivo experiments have demonstrated reduced excretion of lipid peroxidation products after PUFAs intake, and in vitro data have shown that reactive oxygen species are not prone to formation after ω3 FAs supplements. Thus, ω3 FAs may indirectly act as anti- rather than pro-oxidant in vascular endothelial cells, hence diminishing inflammation and, in turn, the risks of atherosclerosis and cardiovascular disease.
In summary, we herein have verified that the lipid fractions from silver carp brain were highly active PAF antagonists, and that NL was mainly responsible for the inhibitory actions of TL. All the lipid fractions were capable of battling bacteria, of which PL was most superb. In the meantime, PL showed higher antiradical activities than TL and NL. The anti-PAF, antibacterial and antiradical activities of the lipid fractions from silver carp brain are conducive to clarifying the protective roles of fish lipids against diseases and probably rendering fish brain efficacious in health boost.
This study was financially supported by the earmarked fund for China Agriculture Research System (CARS-46) and Wujiang Changyang Fishery Ecological Technology Development Corporation.
- Weitz D, Weintraub H, Fisher E, Schwartzbard AZ: Fish oil for the treatment of cardiovascular disease. Cardiol Rev. 2010, 18: 258-263. 10.1097/CRD.0b013e3181ea0de0PubMed CentralView ArticlePubMed
- Bureau of Fisheries of Ministry of Agriculture, PRC, China fishery statistical yearbook of 2011. 2012, Beijing, China: Agricultural press.
- Duan ZH, Wang JL, Yi MH, Yin AQ: Recovery of proteins from silver carp by-products with enzymatic hydrolysis and reduction of bitterness in hydrolysate. J Food Process Eng. 2010, 33: 962-978.
- Stoknes IS, Okland HMW, Falch E, Synnes M: Fatty acid and lipid class composition in eyes and brain from teleosts and elasmobranchs. Comp Biochem Phys B. 2004, 138: 183-191. 10.1016/j.cbpc.2004.03.009.View Article
- Demopoulos CA, Karantonis HC, Antonopoulou S: Platelet activating factor - a molecular link between atherosclerosis theories. Eur J Lipid Sci Tech. 2003, 105: 705-716. 10.1002/ejlt.200300845.View Article
- Nomikos T, Karantonis HC, Skarvelis C, Demopoulos CA, Zabetakis I: Antiatherogenic properties of lipid fractions of raw and fried fish. Food Chem. 2006, 96: 29-35. 10.1016/j.foodchem.2005.01.060.View Article
- Ozturk S, Ercisli S: Antibacterial activity and chemical constitutions of Ziziphora clinopodioides. Food Control. 2007, 18: 535-540. 10.1016/j.foodcont.2006.01.002.View Article
- Ogata M, Nandate K, Kawasaki T, Kawasaki C, Ozaki M, Shigematsu A: A platelet activating factor receptor antagonist inhibits cytokine production in human whole blood by bacterial toxins and live bacteria. Anesth Analg. 2004, 98: 1767-1772.View ArticlePubMed
- Antonopoulou S, Semidalas CE, Koussissis S, Demopoulos CA: Platelet-activating factor (PAF) antagonists in foods: a study of lipids with PAF or anti-PAF-like activity in cow’s milk and yogurt. J Agr Food Chem. 1996, 44: 3047-3051. 10.1021/jf950619y.View Article
- Nasopoulou C, Karantonis HC, Andriotis M, Demopoulos CA, Zabetakis I: Antibacterial and anti-PAF activity of lipid extracts from sea bass (Dicentrarchus labrax) and gilthead sea bream (Sparus aurata). Food Chem. 2008, 111: 433-438. 10.1016/j.foodchem.2008.04.011.View ArticlePubMed
- Nasopoulou C, Tsoupras AB, Karantonis HC, Demopoulos CA, Zabetakis I: Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism. Lipids Health Dis. 2011, 10:
- Mishra PM, Sree A, Acharya M, Das AP: Fatty acid profile, volatiles and antibacterial screening of lipids of the sponge Fasciospongia cavernosa (Schmidt) collected from the Bay of Bengal (Orissa Coast). J Serb Chem Soc. 2009, 74: 1241-1248. 10.2298/JSC0911241M.View Article
- Shipar MAH: Physical and chemical characteristics, major fatty acids, antimicrobial activity and toxicity analysis of red shrimp (Metapenaeus brevicornis) brain lipid. Food Chem. 2007, 102: 649-655. 10.1016/j.foodchem.2006.05.044.View Article
- Davletshina TA, Shul’gina LV, Lazhentseva LI, Blinov IG, Pivnenko TN: Inhibitory effect of antimicrobial preparation from lipids of marine fishes on tissue and microbial enzymes. Prikl Biokhim Mikrobiol. 2003, 39: 676-680.PubMed
- Ting HC, Hsu YW, Tsai CF, Lu FJ, Chou MC, Chen WK: The in vitro and in vivo antioxidant properties of seabuckthorn (Hippophae rhamnoides L) seed oil. Food Chem. 2011, 125: 652-659. 10.1016/j.foodchem.2010.09.057.View Article
- Nitta H, Kinoyama M, Watanabe A, Shirao K, Kihara H, Arai M: Effects of nutritional supplementation with antioxidant vitamins and minerals and fish oil on antioxidant status and psychosocial stress in smokers: an open trial. Clin Exp Med. 2007, 7: 179-183. 10.1007/s10238-007-0144-yView ArticlePubMed
- Jahangiri A, Leifert WR, Kind KL, McMurchie EJ: Dietary fish oil alters cardiomyocyte Ca2+ dynamics and antioxidant status. Free Radical Bio Med. 2006, 40: 1592-1602. 10.1016/j.freeradbiomed.2005.12.026.View Article
- Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J bio chem. 1957, 226: 497-509.
- Galanos DS, Kapoulas VM: Isolation of polar lipids from triglyceride mixtures. J Lipid Res. 1962, 1–3: 134-137.
- Demopoulos CA, Pinckard RN, Hanahan DJ: Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Bio Chem. 1979, 19: 9355-9358.
- (National Committee for Clinical Laboratory Standards). Performance standards for antimicrobial susceptibility test. 1999, Wayne: NCCLS.
- Tian H, Zhang H, Zhan P, Tian F: Composition and antioxidant and antimicrobial activities of white apricot almond (Amygdalus communis L.) oil. Eur J Lipid Sci Tech. 2011, 113: 1138-1144. 10.1002/ejlt.201000514.View Article
- Strobel C, Jahreis G, Kuhnt K: Survey of n-3 and n-6 polyunsaturated fatty acids in fish and fish products. Lipids Health Dis. 2012, 11:
- Mori TA, Beilin LJ, Burke V, Morris J, Ritchie J: Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscl Throm Vas. 1997, 17: 279-286. 10.1161/01.ATV.17.2.279.View Article
- Nasopoulou C, Nomikos T, Demopoulos CA, Zabetakis I: Comparison of antiatherogenic properties of lipids obtained from wild and cultured sea bass (Dicentrarchus labrax) and gilthead sea bream (Sparus aurata). Food Chem. 2007, 100: 560-567. 10.1016/j.foodchem.2005.09.074.View Article
- Som CRS, Radhakrishnan CK: Antibacterial activities of polyunsaturated fatty acid extracts from Sardinella longiceps and Sardinella fimbriata. Indian J Geo-Mar Sci. 2011, 40: 710-716.
- Ouattara B, Simard RE, Holley RA, Piette GJ, Begin A: Antibacterial activity of selected fatty acids and essential oils against six meat spoilage organisms. Int J Food Microbiol. 1997, 37: 155-162. 10.1016/S0168-1605(97)00070-6View ArticlePubMed
- Zheng CJ, Yoo JS, Lee TG, Cho HY, Kim YH, Kim WG: Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Lett. 2005, 579: 5157-5162. 10.1016/j.febslet.2005.08.028View ArticlePubMed
- Mil-Homens D, Bernardes N, Fialho AM: The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia. FEMS Microbiol Lett. 2012, 328: 61-69. 10.1111/j.1574-6968.2011.02476.xView ArticlePubMed
- Boselli E, Pacetti D, Lucci P, Frega NG: Characterization of Phospholipid Molecular Species in the Edible Parts of Bony Fish and Shellfish. J Agri Food Chem. 2012, 60: 3234-3245. 10.1021/jf205159a.View Article
- Kawabori M, Kacimi R, Karliner JS, Yenari MA: Sphingolipids in cardiovascular and cerebrovascular systems: pathological implications and potential therapeutic targets. World J Cardiol. 2013, 5: 75-86. 10.4330/wjc.v5.i4.75PubMed CentralView ArticlePubMed
- Duan J, Sugawara T, Hirata T: Rapid Quantitative Analysis of Sphingolipids in Seafood Using HPLC with Evaporative Light-Scattering Detection: Its Application in Tissue Distribution of Sphingolipids in Fish. J Oleo Sci. 2010, 59: 509-513. 10.5650/jos.59.509View ArticlePubMed
- Duan R-D, Nilsson A: Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development. Prog Lipid Res. 2009, 48: 62-72. 10.1016/j.plipres.2008.04.003View ArticlePubMed
- Richard D, Kefi K, Barbe U, Bausero P, Visioli F: Polyunsaturated fatty acids as antioxidants. Pharmacol Res. 2008, 57: 451-455. 10.1016/j.phrs.2008.05.002View ArticlePubMed
- Mori TA: Effect of fish and fish oil-derived omega-3 fatty acids on lipid oxidation. Redox Rep. 2004, 9: 193-197. 10.1179/135100004225005200View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.